SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Jun. 21, 2022– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the release of its first environmental, social and governance (ESG) report.
“At CareDx, our mission and 100% dedication to improving the transplant ecosystem with innovative and intelligent solutions to improve patient outcomes shapes every aspect of our business and seamlessly integrates with an ESG framework,” said Reg Seeto, CareDx CEO and President. “As a leader in transplantation, we have a great responsibility to the transplant community, and using this framework is a natural step in our company’s evolution as we search for ways to continue to exemplify our values through actions which have a meaningful impact on our community, patients, and other stakeholder groups.” Read the full press release on CareDx.com here.